Related Experiment Videos
Lower limb ischaemia in primary antiphospholipid syndrome
European Journal of Vascular Surgery
|July 1, 1993
Summary
Primary antiphospholipid syndrome (PAPS) significantly increases the risk of graft thrombosis in lower limb ischemia patients. Optimal anticoagulation during and after surgery is crucial for vascular procedure success in these individuals.
Area of Science:
- Vascular Surgery
- Autoimmune Disorders
- Rheumatology
Background:
- Primary antiphospholipid syndrome (PAPS) is an autoimmune condition causing recurrent venous and arterial thrombosis.
- Lower limb ischemia presents a significant clinical challenge in patients with PAPS.
Purpose of the Study:
- To investigate the outcomes of vascular surgical procedures in patients with lower limb ischemia secondary to PAPS.
- To determine the risk factors for graft failure and identify optimal perioperative management strategies.
Main Methods:
- Retrospective case series of seven patients with PAPS and lower limb ischemia.
- Review of patient history, clinical presentation, diagnostic tests (including antiphospholipid antibody testing), angiographic findings, and treatment outcomes.
- Analysis of vascular surgical procedures, including percutaneous transluminal angioplasty and bypass grafting, and their associated complications.
Main Results:
- All seven patients experienced lower limb ischemia, with symptoms including claudication, rest pain, and gangrene.
- Angiography revealed arterial thrombosis in multiple segments (aorta, iliac, femoral, popliteal).
- Vascular surgery in four patients resulted in a high rate of early postoperative graft thrombosis (10 out of 11 procedures), with only one graft remaining patent when full heparinization was employed perioperatively.
Conclusions:
- PAPS patients with lower limb ischemia face a high risk of graft thrombosis following vascular interventions.
- Perioperative and long-term full anticoagulation is essential for improving graft patency in these high-risk patients.
- Vascular surgery should be approached with extreme caution and aggressive anticoagulation protocols in the setting of PAPS.